Indefinite Delivery Contract HHSN272201600001I

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded this $112 million Indefinite Delivery Contract to Battelle Memorial Institute, a large nonprofit research and development organization, for "Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases." The contract provides a comprehensive suite of preclinical, nonclinical, and clinical testing services to...

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $102.5 million Indefinite Delivery Contract to Battelle Memorial Institute to provide research, development, testing, and evaluation services for vaccines and other biologics for infectious diseases. Under this contract, Battelle has been issued numerous cost-plus-fixed-fee and cost-plus-award-fee delivery orders to support NIAID's programs....

The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded an indefinite delivery contract to Pharmaceutical Research Associates Inc., doing business as PRA, with a potential value of $250 million. The contract provides for clinical trials planning and execution services in support of the Clinical Studies Network. PRA was issued a $200,000 delivery order for one base year of performance ending September 2021 to conduct clinical trial...

This indefinite delivery contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the Southern Research Institute, a non-profit research organization located in Birmingham, Alabama. The contract has a ceiling value of $136,588,701.00 and a period of performance from September 30, 2025 to September 29, 2035. The purpose of this contract is to provide "EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR...

The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a single award Indefinite Delivery Contract to Charles River Laboratories, Inc. to provide clinical trial materials for virus vaccines with a maximum ordering value of $24,519,468.00 over a seven year period from February 2021 through February 2028. Under this contract vehicle, the agency has issued multiple firm fixed price delivery orders to Charles River for services including the production of...

This indefinite delivery contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract, valued at a ceiling of $136,588,701, is for evaluation and testing services (ETS) for vaccines and other biologics for infectious diseases. The contract is a single-award indefinite delivery vehicle with a period of performance from...

This is a multiple award Indefinite Delivery Contract (IDC) awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to provide comprehensive early phase clinical trial services. The $346.6 million contract, titled "Early Phase Clinical Trial Units (EPCTU)", facilitates Phase 0 through Phase II trials of investigational products against infectious diseases over a 10-year ordering period from...

This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business. The $18 million multiple-award contract, titled "VACCINE RESEARCH CENTER CLINICAL MONITORING INITIATIVE", covers a range of clinical trials execution, regulatory support,...

This is a single-award Indefinite Delivery Contract (IDC) issued by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a contract research and manufacturing organization. The base contract has a potential value of $124,500,000 and a period of performance through September 28, 2028. The purpose is to provide NIAID Preclinical Development Support...

This single-award IDV was issued by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to provide centralized clinical laboratory services in support of clinical research trials. With a potential value of $5,000,000 and a period of performance through May 2026, the awardee PPD Development LP will deliver services including specimen handling, testing, data management, and clinical trial support. The originating...